[1]Mario FM. Early-Onset Alzheimer’s Disease. Neurol Clin. 2017 May; 35(2): 263–281. doi: 10.1016/j.ncl.2017.01.005.
[2] Rita C, Kristel S, Christine V. Molecular genetics of early-onset Alzheimer's disease revisited. Alzheimer's & Dementia June 2016,12(6):733-748.doi: 10.1016/j.jalz.2016.01.012.
[3] Limin M, Jiewen Z, Yingying S, Wan W, Zhixia R, Mingrong X, et al. Gene mutations in a Han Chinese Alzheimer's disease cohort, Brain Behav. 2019 Jan; 9(1): e01180. doi: 10.1002/brb3.1180.
[4]Bagyinszky E, Giau VV, Shim K, Suk K, An SSA, Kim SY. Role of inflammatory molecules in the Alzheimer’s disease progression and diagnosis. J. Neurol. Sci. 2017;376:242–254. doi: 10.1016/j.jns.2017.03.031.
[5]Lambert MA, Bickel H, Prince M, Fratiglioni L, Von Strauss E, Frydecka D, et al. Estimating the burden of early onset dementia; systematic review of disease prevalence. Eur J Neurol. 2014;21(4):563–569. doi: 10.1111/ene.12325.
[6]Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature. 1995;375:754–760. doi: 10.1038/375754a0.
[7]Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science. 1995;269:973–977. doi: 10.1126/science.7638622.
[8]Giau VV, Pyun J-M, Bagyinszky E, An SSA, Kim S. A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease. Clin. Interv. Aging. 2018;13:1321–1329. doi: 10.2147/CIA.S170374.
[9]Giau VV, Bagyinszky E, An SSA, Kim S. Clinical genetic strategies for early onset neurodegenerative diseases. Mol. Cell. Toxicol. 2018;14:123–142.doi: 10.1007/s13273-018-0015-3
[10]Dickson DW, Kouri N, Murray ME, Josephs KA. Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau). J Mol Neurosci 2012;45:384–9. doi: 10.1007/s12031-011-9589-0.
[11]Spillantini MG, Goedert M. Tau pathology and neurodegeneration. Lancet Neurol. 2013;12:609–22. doi: 10.1016/S1474-4422(13)70090-5.
[12]Zhang CC, Xing A, Tan MS, Tan L, Yu JT. The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy. Mol Neurobiol. 2016 Sep;53(7):4893-904. doi: 10.1007/s12035-015-9415-8.
[13] He S, Chen S, Xia MR, Sun ZK, Huang Y, Zhang JW. The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review. Neuropsychiatr Dis Treat. 2018; 14: 1627–33. doi: 10.2147/NDT.S155521.